Jacquelyn A Hatch-Stein1, Babette S Zemel2, Divya Prasad1, Heidi J Kalkwarf3, Mary Pipan4, Sheela N Magge5, Andrea Kelly1. 1. Divisions of Endocrinology and Diabetes. 2. Gastroenterology, Hepatology, and Nutrition, and zemel@email.chop.edu. 3. Division of General and Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and. 4. Behavioral Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 5. Division of Endocrinology and Diabetes, Children's National Health System, Washington, District of Columbia.
Abstract
BACKGROUND AND OBJECTIVES: New US Down syndrome (DS) BMI growth charts were recently published, but their utility in identifying children with excess adiposity or increased cardiometabolic risk (CMR) remains unknown. We sought to compare the ability of the Centers for Disease Control and Prevention (CDC) BMI 85th percentile and DS-specific BMI 85th percentile to identify excess adiposity in children with DS. METHODS: Participants with DS aged 10 to 20 years were enrolled in a cross-sectional CMR study. Data from typically developing children enrolled in the Bone Mineral Density in Childhood Study (BMDCS) were used for comparison. Sensitivity and specificity were calculated to assess the CDC BMI 85th percentile in the BMDCS and DS groups, and the DS-specific BMI 85th percentile in the DS group, relative to fat mass index (FMI) ≥80th percentile, a threshold associated with increased CMR. RESULTS: Included were 121 DS participants (age 14.8 ± 3.3 years, 57% girls) and 7978 BMDCS reference data points (age 15.0 ± 3.0 years, 51.3% girls). The CDC BMI 85th percentile identified FMI ≥80th percentile with 96.9% sensitivity and 87.4% specificity in typically developing children. Similarly, the CDC BMI 85th percentile identified FMI ≥80th percentile with 100% sensitivity and 78.3% specificity in children with DS. In contrast, the sensitivity of the DS-specific BMI 85th percentile was only 62.3% (P < .0001), but was 100% specific. CONCLUSIONS: For children with DS ≥10 years, the CDC BMI growth chart 85th percentile is a better indicator of excess adiposity, than the new DS-specific BMI charts. Additional studies are needed to clarify the relationships of BMI and FMI with CMR in DS.
BACKGROUND AND OBJECTIVES: New US Down syndrome (DS) BMI growth charts were recently published, but their utility in identifying children with excess adiposity or increased cardiometabolic risk (CMR) remains unknown. We sought to compare the ability of the Centers for Disease Control and Prevention (CDC) BMI 85th percentile and DS-specific BMI 85th percentile to identify excess adiposity in children with DS. METHODS:Participants with DS aged 10 to 20 years were enrolled in a cross-sectional CMR study. Data from typically developing children enrolled in the Bone Mineral Density in Childhood Study (BMDCS) were used for comparison. Sensitivity and specificity were calculated to assess the CDC BMI 85th percentile in the BMDCS and DS groups, and the DS-specific BMI 85th percentile in the DS group, relative to fat mass index (FMI) ≥80th percentile, a threshold associated with increased CMR. RESULTS: Included were 121 DS participants (age 14.8 ± 3.3 years, 57% girls) and 7978 BMDCS reference data points (age 15.0 ± 3.0 years, 51.3% girls). The CDC BMI 85th percentile identified FMI ≥80th percentile with 96.9% sensitivity and 87.4% specificity in typically developing children. Similarly, the CDC BMI 85th percentile identified FMI ≥80th percentile with 100% sensitivity and 78.3% specificity in children with DS. In contrast, the sensitivity of the DS-specific BMI 85th percentile was only 62.3% (P < .0001), but was 100% specific. CONCLUSIONS: For children with DS ≥10 years, the CDC BMI growth chart 85th percentile is a better indicator of excess adiposity, than the new DS-specific BMI charts. Additional studies are needed to clarify the relationships of BMI and FMI with CMR in DS.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Deirdre A Hill; Gloria Gridley; Sven Cnattingius; Lene Mellemkjaer; Martha Linet; Hans-Olof Adami; Jorgen H Olsen; Olof Nyren; Joseph F Fraumeni Journal: Arch Intern Med Date: 2003-03-24
Authors: Babette S Zemel; Mary Pipan; Virginia A Stallings; Waynitra Hall; Kim Schadt; David S Freedman; Phoebe Thorpe Journal: Pediatrics Date: 2015-11 Impact factor: 7.124
Authors: Ibrahim Elsharkawi; David Gozal; Eric A Macklin; Lauren Voelz; Gil Weintraub; Brian G Skotko Journal: Sleep Med Date: 2017-03-07 Impact factor: 3.492
Authors: Amanda G Ruiz; Dexiang Gao; David G Ingram; Francis Hickey; Matthew A Haemer; Norman R Friedman Journal: J Pediatr Date: 2019-05-10 Impact factor: 4.406
Authors: Kathleen J Motil; Suzanne Geerts; Fran Annese; Jeffrey L Neul; Tim Benke; Eric Marsh; David Lieberman; Steven A Skinner; Daniel G Glaze; Peter Heydemann; Arthur Beisang; Shannon Standridge; Robin Ryther; Jane B Lane; Lloyd Edwards; Alan K Percy Journal: J Pediatr Date: 2022-01-19 Impact factor: 6.314